PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Interestingly, the PNPLA3 G/G genotype carriers were more sensitive to the beneficial effects of lifestyle modification (i.e., the reduction in TG, total cholesterol, LDL-C, body weight and the waist to hip ratio), despite the G/G genotype carriers had a higher risk for NAFLD [33].